Keith Manchester - Sep 28, 2023 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
Director
Signature
/s/ Keith Manchester
Stock symbol
ROIV
Transactions as of
Sep 28, 2023
Transactions value $
-$79,650,463
Form type
4
Date filed
10/2/2023, 09:05 PM
Previous filing
Sep 14, 2023
Next filing
Mar 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Sale -$26.4M -2.29M -8.16% $11.55 25.7M Sep 28, 2023 Held by QVT Deferred Compensation Holdings Ltd F1
transaction ROIV Common Shares Sale -$35.3M -3.06M -8.16% $11.55 34.4M Sep 28, 2023 Held by QVT Financial Investment Cayman Ltd. F1
transaction ROIV Common Shares Sale -$12.8M -1.1M -8.16% $11.55 12.4M Sep 28, 2023 Held by QVT Roiv Hldgs Onshore Ltd F1
transaction ROIV Common Shares Sale -$5.16M -446K -8.16% $11.55 5.02M Sep 28, 2023 Held by QVT P&E Roiv Hldgs Ltd. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is a shareholder of each of QVT Roiv Hldgs Onshore Ltd., QVT Deferred Compensation Holdings Ltd., QVT P&E Roiv Hldgs Ltd. and QVT Financial Investment Cayman Ltd. (the "QVT Entities") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.